Molecular basis of thalassemia in Qatar

Hemoglobin

Volumn 31, Issue 2, 2007, Pages 121-127

  Al Obaidli, Aisha ^a   Hamodat, Mowafak ^b   Fawzi, Zainab ^c   Abu Laban, Mohamed ^c   Gerard, Nathalie ^d   Krishnamoorthy, Rajagopal ^d  

^a QATAR UNIVERSITY   (Qatar)

^b Dukhan Medical Center   (Qatar)

^c HAMAD MEDICAL CORPORATION   (Qatar)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Thalassemia (thal); Mutation; Qatar; Spectrum

Indexed keywords

ALLELE; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; ETHNICITY; GENE MUTATION; HUMAN; HUMAN CELL; MICROCYTIC ANEMIA; MOLECULAR GENETICS; POPULATION RESEARCH; QATAR; SICKLE CELL ANEMIA;

AMINO ACID SUBSTITUTION; BETA-THALASSEMIA; CODON; DNA; HETEROZYGOTE DETECTION; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; QATAR;

EID: 34248188069     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260701288815     Document Type: Article

References (25)

1. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science, 2001.
2. Hardison RC, Chui DHK, Giardine B, Reimer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. HbVar: a relational data base of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002; 19(3):225-233 (http://globin.cse.psu.edu).
3. Patrinos GP, Giardine B, Reimer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. Improvements in the HbVar human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32(Database issue):D537-D541 (http://globin.cse.psu.edu).
4. Al-Ali AK, Al-Ateeq S, Imamwerdi BW, Al-Sowayan S, Al-Madan M, Al-Muhanna F, Bashaweri L, Qaw F. Molecular bases of β-thalassemia in the eastern province of Saudi Arabia. J Biomed Biotechnol 2005; 2005(4):322-325.
5. S haplotypes among Kuwaiti Arabs. Acta Haematol 1994; 92(4):176-181.
6. Jassim N, Merghoub T, Pascaud O, Al Mukharraq H, Ducrocq R, Labie D, Elion J, Krishnamoorthy R, Arrayed SA. Molecular basis of β-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann NY Acad Sci 1998; 850:407-409.
7. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann NY Acad Sci 1998; 850:404-406.
8. Fawzi ZO, Al Halali A, Fakhroo N, Al Bin Ali A, Al Mansour S. Distribution of hemoglobinopathies and thalassemias in Qatari Nationals seen at Hamad Hospital in Qatar. Qatar Med J 2003; 12(1): 20-24.
9. Cai SP, Wall J, Kan YW, Chehab FF. Reverse dot blot probes for screening of β-thalassemia mutations in Asians and Americans blacks. Hum Mutat 1994; 3(1):59-63.
10. Maggio A, Giambona A, Cai SP, Wall J, Kan YW, Chehab FF. Rapid and simultaneous typing of Hemoglobin S, Hemoglobin C, and seven Mediterranean β-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood 1993; 81(1):239-242.
11. Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, Goossens M. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum Mutat 1992; 1(3):229-239.
12. T-Saudi (AATAAA→AATAAG) in the α2-globin gene. Hemoglobin 1999; 23(3):213-220.
13. Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994; 46(3):208-213.
14. Orkin SH, Sexton JP, Goff SC, Kazazian HH. Inactivation of an acceptor RNA splice site by a short deletion in β-thalassemia. J Biol Chem 1983; 258(12):7249-7251.
15. 0-thalassemia. Proc Natl Acad Sci USA 1979; 76(5):2400-2404.
16. Quaife R, Al-Gazali L, Abbes S, Fitzgerald P, Fitches A, Valler D, Old JM. The spectrum of β thalassemia mutations in the UAE national population. J Med Genet 1994; 31(1):59-61.
17. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001, 25(3):285-296.
18. Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin 2001; 25(1):35-43.
19. Zahed L. The spectrum of β-thalassemia mutations in the Arab populations. J Biomed Biotech 2001; 1(3):129-132.
20. anti3.7 triplication by enzymatic amplification analysis. Br J Haematol 1992; 82(1):105-111.
21. Driscoll MC, Dobkin CS, Alter BP. γδβ-Thalassemia due to a de novo mutation deleting the 5′ β-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci USA 1989; 86(19):7470-7474.
22. Ho PJ, Hall GW, Watt S, West NC, Wimperis JW, Wood WG, Thein SL. Unusually severe heterozygous β-thalassemia: evidence for an interacting gene affecting globin translation. Blood 1998; 92(9):3428-3435.
23. 3.7 deletion and the rare IVS-I-116 (A→G) acceptor splice site mutation. Br J Haematol 1998; 103(2):370-376.
24. Faa V, Meloni A, Moi L, Ibba G, Travi M, Vitucci A, Cao A, Rosatelli MC. Thalassaemia-like carriers not linked to the β-globin gene cluster. Br J Haematol 2006; 132(5):640-650.
25. Kihm AJ, Kong Y, Wong W, Russell JE, Bouda S, Adachi K, Simon MC, Blobel GA, Weiss MJ. An abundant erythroid protein that stabilizes free α-haemoglobin. Nature 2002; 417(6890):758-763.